About Prometheus Laboratories
Prometheus Laboratories is a company based in San Diego (United States) founded in 1995 was acquired by Nestlé Health Science in May 2011.. The company has 474 employees as of December 31, 2022. Prometheus Laboratories offers products and services including Anser IFX, Anser ADA, Monitr IBD, and Celiac Plus. Prometheus Laboratories operates in a competitive market with competitors including Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals, Given Imaging and EnteraSense, among others.
- Headquarter San Diego, United States
- Employees 474 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Prometheus Laboratories Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$260 M (USD), Debt – Conventional
Jan 07, 2010
-
Investors
Nestlé Health Science
& 2 more
-
Employee Count
474
as on Dec 31, 2022
-
Acquired by
Nestlé Health Science
(May 24, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Prometheus Laboratories
Prometheus Laboratories offers a comprehensive portfolio of products and services, including Anser IFX, Anser ADA, Monitr IBD, and Celiac Plus. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Monitors infliximab levels for effective IBD treatment management.
Assesses adalimumab levels in patients with gastrointestinal conditions.
Evaluates disease activity for inflammatory bowel disease monitoring.
Detects celiac disease through genetic and serological analysis.
Unlock access to complete
Unlock access to complete
Software Development Team
17 people
Leadership Team
11 people
Sales and Marketing
6 people
Operations Team
4 people
Senior Team
4 people
Human Resources and Administration
2 people
Product Management Team
2 people
Sr. Team
2 people
Unlock access to complete
Funding Insights of Prometheus Laboratories
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $260.0M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2010 | Amount | Debt – Conventional - Prometheus Laboratories | Valuation |
investors |
|
| Nov, 2009 | Amount | Grant - Prometheus Laboratories | Valuation |
investors |
|
| Jun, 1999 | Amount | Series B - Prometheus Laboratories | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Prometheus Laboratories
Prometheus Laboratories has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Nestlé Health Science, Pamlico Capital and National Science Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pamlico Capital is engaged in private equity investments for growth companies.
|
Founded Year | Domain | Location | |
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Founded Year | Domain | Location | |
|
Nutritional dietary supplements are provided for health and wellness needs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Prometheus Laboratories
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Prometheus Laboratories
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Prometheus Laboratories Comparisons
Competitors of Prometheus Laboratories
Prometheus Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals, Given Imaging and EnteraSense, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| domain | founded_year | HQ Location |
Optical coherence tomography systems for tissue microstructure imaging are developed.
|
|
| domain | founded_year | HQ Location |
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
|
|
| domain | founded_year | HQ Location |
Capsule endoscopy systems for GI imaging
|
|
| domain | founded_year | HQ Location |
Ingestible biosensor for GI disease
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Prometheus Laboratories
Frequently Asked Questions about Prometheus Laboratories
When was Prometheus Laboratories founded?
Prometheus Laboratories was founded in 1995 and raised its 1st funding round 4 years after it was founded.
Where is Prometheus Laboratories located?
Prometheus Laboratories is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Prometheus Laboratories?
Joseph Limber is the current CEO of Prometheus Laboratories.
How many employees does Prometheus Laboratories have?
As of Dec 31, 2022, the latest employee count at Prometheus Laboratories is 474.
What does Prometheus Laboratories do?
Prometheus Laboratories develops diagnostics for the gastrointestinal space. As of Jan 2016, it offers diagnostics for patient responsiveness to infliximab and adalimumab, irritable bowel syndrome, celiac disease, thipurine metabolite and liver fibrosis in Hep C patients, and prognostics for Crohns disease. In addition, the company also provides genetic tests for lactose intolerance and a therapeutic product proleukin for metastatic melanoma and kidney cancer. In May 2011, Prometheus became a subsidiary of Nestlé Health Science.
Who are the top competitors of Prometheus Laboratories?
Prometheus Laboratories's top competitors include Viome Life Sciences, NinePoint Medical and InDex Pharmaceuticals.
What products or services does Prometheus Laboratories offer?
Prometheus Laboratories offers Anser IFX, Anser ADA, Monitr IBD, and Celiac Plus.
Who are Prometheus Laboratories's investors?
Prometheus Laboratories has 3 investors. Key investors include Nestlé Health Science, Pamlico Capital, and National Science Foundation.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.